Background. Previous studies have focused on the treatment received by rural cancer patients and have not examined their diagnostic pathways as reasons for poorer outcomes in rural Australia.
Introduction
Rural Australians are more likely to die within 5 years of a cancer diagnosis than people from metropolitan areas. 1 While survival for most common cancers in Australia is improving, the rural-urban differential is actually widening with significant excess deaths in regional Australia due to lung, colorectal, breast and prostate cancers. 2 Previous studies have shown that patients living in rural areas are less likely to receive curative or reconstructive surgery, radiotherapy or hormonal treatment. [3] [4] [5] [6] Policy initiatives have focused therefore on reducing disparities in access to optimal treatment. 7 Access to treatment is an important determinant of outcome, but later presentation and stage at diagnosis have also been observed in rural Australian cancer patients compared with their urban counterparts. 8, 9 Family Practice 2013; 30:541-550 doi:10.1093/fampra/cmt016
Advance Access publication 22 May 2013 International research suggests that management in primary care and access to specialist diagnosis are key determinants of cancer outcomes. 10 Prolonged time to diagnosis is associated with poorer survival for several common cancers. 11, 12 Studies that have relied on administrative data sets to demonstrate later presentation and poorer cancer survival in rural patients in Australia cannot provide a rich explanation for later presentation to health care or a detailed understanding of diagnostic pathways. To understand these problems in fine detail, necessary to inform the design of future interventions, requires in-depth exploratory research. Qualitative studies have explored factors such as distance, time and availability of appointments that affect referral patterns of rural cancer patients, 13 but none has compared these issues across cancers or combined them with quantitative data on actual time to diagnosis. Theoretical models that help explain 'total patient delay' have existed in the literature for many years, 14 but none has been applied previously to rural cancer diagnosis.
This study used a mixed methods approach to explore factors contributing to longer diagnostic intervals in rural cancer patients in Western Australia (WA), comparing intervals between common cancers. We have reported data on symptom appraisal and help seeking intervals in a separate article. 15 This article reports on the interval from patient presentation to health care until cancer diagnosis. The overall objective of this study was to identify the major subcomponents of the diagnostic interval for rural cancer patients in WA to inform the design of an intervention aimed at reducing time to diagnosis. We studied the four commonest cancers expecting that there may be different factors for each tumour, which could therefore inform the design of interventions specific to each cancer.
Methods

Theoretical framework
We applied the Model of Patient Pathways to Treatment 16 to inform our data collection and analysis (Fig. 1) . This model describes two intervals prior to presentation to health care about a symptom: symptom appraisal and help seeking. The diagnostic interval is the time from first presentation until cancer diagnosis, and the total diagnostic interval (TDI) is the sum of these three intervals. Factors that influence the duration of these intervals relate to the patient (e.g. previous experience and social and cultural factors), health care system factors (e.g. access) and tumour (e.g. location and rate of growth).
Study population
From March 2009-April 2010, we recruited patients recently diagnosed and treated for breast, colorectal, prostate or lung cancer. Patients were eligible if their main residence was in either the Goldfields or Great Southern regions of WA. Based on the Accessibility/ Remoteness Index of Australia (ARIA), all Statistical Local Areas (SLAs) in the Goldfields are considered remote or very remote. The ARIA classification aims to quantify relative remoteness in Australia based on the physical road distance to the nearest town or service centre. There are five Remoteness Area Classes: major city, inner regional, outer regional, remote and very remote. Remote and very remote Australia represent approximately 3% of the Australian population. 17 In the Great Southern Region 93% of residents live in SLAs classified as outer regional and the remainder in a remote area. Patients were initially approached about the study by a rural cancer nurse coordinator or via the Cancer Registry and their treating clinician and then consented by the research interviewer. We attempted to approach all patients from these two regions during the recruitment period by one of these two methods. The majority of interviews occurred within 3 months of diagnosis.
Data collection
This was a mixed methods study in which the quantitative data were used to complement the analysis and interpretation of the qualitative data. 18 In-depth semistructured interviews were conducted by researchers (CS, DE and AW) to explore the participants' initial symptoms, their interpretation and factors contributing to their decision to seek help and their experience with the health care system including their attendance in general practice and hospital specialists prior to diagnosis.
Within the interview, participants estimated the dates of onset of their symptoms and initial presentation to a health care provider. A diagram depicting the separate intervals of symptom appraisal and help seeking, including making an appointment and attending a health care provider, was used to support the interviews and collection of quantitative data on dates of these events. In addition, we used a calendar-landmarking technique based on personal and locally relevant events to aid recall about symptom appraisal and help-seeking dates. 19 Participants consented to access to their general practice, specialist and hospital records to obtain dates of attendances, investigations, diagnosis and treatment. Data were extracted by a researcher (DH) using a specific pro forma.
Data analysis
All interviews were transcribed and subjected to Framework analysis. 20 The transcripts were read repeatedly, and an iterative process followed, involving the stages of familiarization with the data, identification of a thematic framework and coding using NVivo software. The thematic framework was developed through analysis of the initial 20 transcripts and was mapped onto the Model of Patient Pathways to Diagnosis. 16 This served to strengthen the underlying theoretical basis for the data collection and analysis. The agreed thematic framework was then applied to the analysis of subsequent transcripts seeking to confirm or refute components of the thematic framework. All transcripts were read and coded by at least two researchers. Regular meetings between coders were held to discuss the thematic framework and interpretation of individual transcripts to ensure consistency of coding. The different backgrounds of researchers were also discussed, including their potential impact on data collection and interpretation. Data saturation for the qualitative data, defined as the absence of new emergent themes, was reached before recruitment ended, and only minor modifications to the thematic framework were made following analysis of the latter 46 transcripts.
For patient-reported dates, we applied published mid-point rules to estimate the actual date where uncertainty existed. 10 Where necessary, a clinical consensus group (JE, FW and DH) reviewed the transcripts to confirm the date of first symptom and first presentation to health care. Intervals were calculated from the interviews and medical records. We divided the diagnostic interval further to include time from first presentation in general practice to referral (GP interval), from date of referral to first attendance at specialist (specialist access interval) and time from first attendance at the specialist to date of diagnosis (specialist interval). 21 The GP interval included the time taken to order and respond to investigations available directly in primary care. A hierarchical approach was used to define date of diagnosis based on the date on the pathology report or first date of clinical diagnosis in the medical record where no pathology was available. 22 The TDI was defined as the time from first symptom to diagnosis. We report the TDI in this article to demonstrate the relative contribution of the diagnostic interval to overall time to diagnosis. For screen-detected cases, we used the date of attendance for the screening test as the initial date in the patient pathway. Screen-detected cases were included because their diagnostic pathway after an initial positive screening test was relevant to the aims of this study.
Time data are invariably skewed and bounded by the absence of negative times. Where data were highly skewed, we applied a log transformation prior to conducting general linear modelling (GLM) to compare intervals between cancers. We therefore report, where appropriate, comparisons of arithmetic or geometric means. We used the GLM, where the dependent variable does not necessarily have to have a normal distribution but the error term in the model should have a standard normal distribution. Since residuals after model fitting approximate the actual Diagnosing cancer in the bush errors, we checked the normality of the residuals to assure the validity of statistical tests using the GLM. We conducted comparisons of intervals across all cancers and then, where appropriate, comparisons between pairs of cancers. We applied a least significant difference correction as a relatively conservative approach to adjust for multiple statistical comparisons. Quantitative data were analysed using SPSS version 18. The treatment received by participants was reviewed by an oncologist and a surgeon (AN and CS) and compared against current national and international treatment guidelines to assess whether access to best treatment was observed in this cohort.
23-29
We developed a mixed methods matrix to triangulate our findings and examine how well the qualitative framework explained the diagnostic pathway in those with longer or shorter intervals. 30 This approach to integrate data allowed us to explore convergence and discrepancy of findings across types of data and identify patterns across cases. 31 
Results
Sixty-six eligible people were recruited and interviewed (43 Goldfields and 23 Great Southern regions; 24 breast, 20 colorectal, 14 prostate and 8 lung cancers; mean age 60.5 years; 28 male and 38 female). In Australia, there are national screening programmes for breast, colorectal and cervical cancers. There were 19 screen-detected cases (9 breast, 2 colorectal and 8 prostate cancers). The sample represented approximately 25% of all cases of the four cancers in the two regions diagnosed during the recruitment period.
32 Tables 1 and 2 summarize the GP, specialist access, specialist and TDIs between tumours. Following log transformation of the data, there was a significant overall difference in GP intervals between tumour groups [geometric mean GP interval, in log days, (95% CI Tests for pairwise differences showed that the mean specialist interval was shorter for breast cancer than colorectal, lung and prostate cancers (P ≤ 0.001, 0.019 and <0.001, respectively). There was a significant difference in overall arithmetic mean TDI (P = 0.046); breast cancer was significantly shorter than colorectal and prostate cancers (P = 0.019 and 0.027, respectively 
Qualitative data
Analysis of the qualitative data identified several important themes that explained these differences in intervals between tumours and between individual cases ( Table 3) .
As we observed for patient's symptom appraisal and help seeking, 15 the nature of the symptoms caused by the underlying tumour influenced doctors' appraisal and consequently affected GP, specialist access and specialist intervals. Participants with non-specific Arithmetic mean and median in days. IQR = Inter-quartile range. symptoms such as fatigue, weight loss or shoulder pain in the absence of other symptoms were more likely to experience longer GP intervals than those who presented with more classical 'red flag' symptoms such as a breast lump or haemoptysis. Patients with nonspecific symptoms usually required the development of such an alarm symptom, deterioration of symptoms or identification of a family history of cancer to prompt further investigation or referral. Those with non-specific symptoms were also more likely to experience longer specialist access and specialist intervals as they were deemed less urgent and therefore experienced longer waiting times. The GP interval often incorporated time to obtain and follow-up blood and radiological investigations. Access to blood tests was rarely problematic, but there was variation in access to radiological investigations, particularly computed tomography scans, which sometimes contributed considerably to the GP interval. Ultrasound-guided breast biopsy was only accessible in certain radiology units limiting capacity for GPs to investigate breast lumps locally. Negative or equivocal results from investigations were often a factor in people with longer GP intervals as they created a false sense of reassurance that serious disease was absent. In a few cases of longer GP intervals, this was partially due to selection of uninformative investigations (because they were all negative) or inadequate safety-netting procedures where patients were not prompted to return with ongoing symptoms.
Variable access to specialists and subsequent specialist investigations such as colonoscopy or transrectal prostatic biopsy were a major contributor to the TDI. Diagnosing cancer in the bush Specialist access was shorter for breast cancer because of shorter waiting times for breast clinics. This was especially true for those with abnormalities detected on mammography or ultrasound that had been ordered by the GP or through breast cancer screening. Shorter breast cancer specialist intervals were also due to onestop assessment clinics, enabling diagnosis after a single specialist visit, often to Perth. Local access to breast biopsy by radiologists was another explanation for shorter specialist intervals for breast cancer. In contrast, participants with colorectal or prostate cancer required at least two specialist visits, sometimes with long periods between the first visit and their diagnostic test. This reflected long waiting times for colonoscopy, especially if the patient was not considered urgent, or the need to travel to Perth for a prostatic biopsy. Shorter specialist access and specialist intervals for colorectal or prostate cancer were observed where patients had been referred to a private specialist in Perth, or where the GP had liaised directly with the local specialist to request an urgent assessment. A specific problem of longer specialist access and specialist intervals was identified during December and January due to reduced clinical services during Christmas and the summer holidays. Several participants with very short TDIs presented as medical emergencies, especially those with lung and colorectal cancers. These acute problems included seizures, acute dyspnoea and bowel obstruction and often reflected relatively late-stage disease. Table 4 presents a mixed methods matrix highlighting the factors associated with longer (>50 days) or shorter (<10 days) GP, specialist access and secialist intervals. The matrix demonstrates good convergence between the quantitative data and qualitative explanatory framework.
Discussion
This is the first study to apply a mixed methods approach to examine diagnostic intervals for rural cancer patients internationally. We showed that the TDI was shorter for breast cancer compared with other common cancers. Prostate cancer took longer along the diagnostic pathway in general practice, at the point of referral and once seen by a specialist. Breast cancer was diagnosed more quickly because its symptoms are often more specific and due to good access to diagnostic tests and specialist one-stop clinics. This study therefore has identified where the important 'bottlenecks' along the diagnostic pathway exist for specific cancers and also highlights factors that contribute to prompter diagnosis, as exemplified by breast cancer. It is informative therefore in designing interventions to reduce the diagnostic interval for specific cancers in rural Australia.
Our approach has enabled a detailed exploration and in-depth comparison of factors underlying significant differences in diagnostic intervals across the four commonest cancers in rural WA. The study is strengthened by the explicit application of a theoretical model of patient pathways to diagnosis and treatment. A limitation of this study is that we recruited only approximately 25% of all the cases of the four cancers in the two regions. 32 This was mainly because, at the time of the study, recruitment via the Cancer Registry relied on an initial approach by the treating clinician, limiting the ability of the research team to follow-up non-responders. It also means we are unable to provide detailed information about non-responders. We had relatively few lung cancer patients partly because several people with lung cancer died before we were able to interview them. We reached data saturation in our qualitative analysis well before the total sample had been interviewed, suggesting that our findings are robust, particularly given the heterogeneity of our sample. We recruited people with one of the four commonest cancers. While this contributed to the heterogeneity of our study population, it allowed us to make important comparisons between cancers that illustrate factors contributing to prompter and later diagnosis. We do not have comparable data from a metropolitan cohort, and it is possible we would have observed similar patterns between cancers. However, evidence already exists for later presentation and stage at diagnosis in rural Australian cancer patients compared with their urban counterparts. 8, 9 Our study was designed to understand why this is to inform the development of interventions to reduce time to diagnosis. Nonetheless, it would be informative to apply our robust methods to conduct further comparative research in rural and urban cohorts.
The length of TDI we observed in many participants in this study has been associated with poorer outcomes in other research. A TDI of more than 3 months is associated with 12% lower 5 year survival from breast cancer. 11 Recently, a U-shaped association has been shown between symptom duration and colorectal cancer survival, such that 3-year mortality increases with a symptom interval greater than 5 weeks. 12 A similar U-shaped association has been demonstrated for lung and prostate cancer. 33 We did not find an association between stage at diagnosis and TDI, but this may be explained by this U-shaped association or limited power to detect a difference.
International studies have shown that diagnostic intervals are shorter for breast cancer than colorectal or prostate but that specialist access and specialist intervals contribute less than patient and GP intervals. 10 In our study, combined specialist access and specialist intervals ranged from 15% to 27% of the mean TDI between cancers, the patient interval (combined symptom appraisal and help-seeking intervals) ranged from 29% to 86% and the GP interval from 9% to 53%. 15 General practice plays a key role along the diagnostic pathway given that over 80% of cancer patients first present to a GP. 23 In our sample, the mean GP interval was greater for prostate and colorectal cancers, suggesting these could be the focus for interventions aimed at reducing cancer diagnostic intervals in primary care. Internationally, various strategies have attempted to improve GPs' investigation and referral of patients with suspected cancer. The UK '2-week wait' clinics aimed to create fast track referral pathways, but the evidence for the effectiveness of this strategy is limited, mainly because of a failure to improve case selection. 24 As the evidence base about the epidemiology of cancer symptoms in primary care builds, 26 this new knowledge needs to be translated into practice to improve case selection for urgent assessment of patients with symptoms suggestive of cancer.
Alternative approaches could be aimed at improving access to diagnostic tests. Specialist access and specialist intervals were greater for colorectal and prostate cancers, suggesting that service innovations to improve access to colonoscopy and transrectal prostate biopsy should be considered. This could include consideration of direct access to colonoscopy, novel methods of triaging referrals for colonoscopy 22 or one-stop assessment clinics, modelling those successfully established in breast cancer and haematuria. 34, 35 Regional diagnostic centres designed to improve direct access to diagnostic tests closer to home could be particularly relevant to rural Australia where diagnostic services are often centralized in larger cities. 34 Our findings provide potential explanations for previous Australian research showing that rural people with cancer may experience longer diagnostic pathways and greater difficulty accessing specialist care. 13, 36 Previous studies have reported that rural patients are less likely to receive optimal treatment, 25 but in our sample the vast majority had been treated according to current recommendations.
Internationally, there is significant interest in the effect of 'diagnostic delay' and attempts to reduce diagnostic intervals, especially in countries that have poorer cancer outcomes such as Denmark and the UK. 37 This study provides a richer understanding for some of the key factors that may contribute to 'diagnostic delay' experienced by rural Australians with cancer and has informed the development of targeted interventions, currently being tested in a randomized controlled trial, to promote earlier diagnosis and improve the chances of survival.
